The disjointed health care system that patients face today blocks a significant proportion of them from accessing life-changing, innovative drugs, prompting many in the biopharma industry to explore ...

Wylie, ADL’s US managing partner, just moved his 45-person Boston team into larger digs, leasing about 5,500 square feet at 176 Summer St.

"Dave's expertise in pharma and technology, and his ability to help companies scale with clarity and purpose, are exactly what DataJoint needs at this inflection point," said Jim Olson, CEO of ...

Zealand Pharma plans to open a new research facility in Boston, part of the obesity drugmaker’s effort to expand its presence in the US. The Danish company will likely hire between 50 and 100 people ...

Explore pharmaceutical companies to know 2026 delivering innovative pharmacy solutions and improving patient care across the U.S.

Proven human resources and organizational strategist brings more than two decades of leadership across the pharmaceutical industryAppointment ...

Amid growing regulatory pressures, including IRA pricing reforms, RevSavvy reports increasing adoption of its ARC platform and consulting services to help pharmaceutical companies manage system ...

Veeva is paying approximately $100 million to acquire Ostro, according to this week’s announcement, comprising a combination ...

“Strategic transformations are a common and often successful approach in biotechnology,” Rami Levin, who took over as CEO of ...

New Advisors Bring 50+ Years of Leadership Experience With 2 of the Top 10 Global Pharmaceuticals CompaniesJericho, New York, March 11, 2026 ...

Whether happening in public or private, biopharma M&A is fiercer than ever. Experts point to patent pressures, herd mentality ...